Clinical Trial Update: The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation [Phase 1]

View source ↗

Summary

The JET Study, a Phase I trial of cabazitaxel with radiotherapy and long-term androgen deprivation for prostate cancer, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cabazitaxel (cabazitaxel)

Snippet

Sponsor: Nova Scotia Cancer Centre | Conditions: Prostatic Neoplasms | Phase 1 | Status: WITHDRAWN